A Perspective to Combat Covid-19 Disease: Manufacturing and Formulating Inhalable Pharmaceuticals

DOI

10.2991/aer.k.220131.003How to use a DOI?

Keywords

Covid-19; inhale; droplets; pulmonary administration strategy

Abstract

Since its break out in 2019, the Covid - 19 pandemic has affected many aspects of life. The viral disease even endangers human civilization due to the highly virulent and fatality of its effect. The virus has been known to disturb human pulmonary system through cytokine storm occurrence. The pulmonary system, other than being the entrance of the disease has also been known for its potential of direct systemic treatment for many illnesses. Thus, the lungs provide opportunity to retaliate the disease virus infections. This short article is written to overlook possibility to combat the disease through pulmonary administration strategy. The focus of the article will be on existing technology to produce particles suitable for this application. Experience from treatment of other diseases prior to the emergence of this pandemic could be useful to exploit, for future patients treatment.

Copyright

© 2022 The Authors. Published by Atlantis Press International B.V.

Open Access

This is an open access article under the CC BY-NC license.

Download article (PDF)

TY  - CONF
AU  - Amilia Firman Kurniawansyah
AU  - Agung Kridoyono
PY  - 2022
DA  - 2022/02/01
TI  - A Perspective to Combat Covid-19 Disease: Manufacturing and Formulating Inhalable Pharmaceuticals
BT  - Proceedings of the Conference on Broad Exposure to Science and Technology 2021 (BEST 2021)
PB  - Atlantis Press
SP  - 16
EP  - 20
SN  - 2352-5401
UR  - https://doi.org/10.2991/aer.k.220131.003
DO  - 10.2991/aer.k.220131.003
ID  - Kurniawansyah2022
ER  -